Open AccessCombination antihypertensive therapy with amlodipine and rilmenidine (according to ALTAIR Study data)
Author(s) -
E. Shlyakhto,
А. О. Конради
Publication year - 2007
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2007-13-2-156-159
Subject(s) - amlodipine , rilmenidine , combination therapy , medicine , concomitant , pharmacology , population , safety profile , metabolic syndrome , blood pressure , adverse effect , obesity , receptor , environmental health , agonist
The manuscript addresses subanalysis of ALTAIR Study population being on combination therapy of rilmenidine and amlodipine. The efficacy and safety of such combination is shown. Possible decrease in side effects caused by rational drug combination is discussed, as well as positive metabolic changes and body mass reduction is documented in this subgroup. This allows to recommend such combination of antihypertensive drugs for patients with concomitant pathology including so-called metabolic syndrome.